92 related articles for article (PubMed ID: 15655377)
1. Nuclear receptors as negative modulators of STAT3 in multiple myeloma.
Wang LH; Yang XY; Zhang X; Farrar WL
Cell Cycle; 2005 Feb; 4(2):242-5. PubMed ID: 15655377
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells.
Wang LH; Yang XY; Zhang X; Huang J; Hou J; Li J; Xiong H; Mihalic K; Zhu H; Xiao W; Farrar WL
Immunity; 2004 Feb; 20(2):205-18. PubMed ID: 14975242
[TBL] [Abstract][Full Text] [Related]
3. Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3.
Wang LH; Yang XY; Mihalic K; Xiao W; Li D; Farrar WL
J Biol Chem; 2001 Aug; 276(34):31839-44. PubMed ID: 11429412
[TBL] [Abstract][Full Text] [Related]
4. Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells.
Hodge DR; Xiao W; Wang LH; Li D; Farrar WL
Cancer Biol Ther; 2004 Feb; 3(2):188-94. PubMed ID: 14726660
[TBL] [Abstract][Full Text] [Related]
5. The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies.
Stubbs MC; Burn TC; Sparks R; Maduskuie T; Diamond S; Rupar M; Wen X; Volgina A; Zolotarjova N; Waeltz P; Favata M; Jalluri R; Liu H; Liu XM; Li J; Collins R; Falahatpisheh N; Polam P; DiMatteo D; Feldman P; Dostalik V; Thekkat P; Gardiner C; He X; Li Y; Covington M; Wynn R; Ruggeri B; Yeleswaram S; Xue CB; Yao W; Combs AP; Huber R; Hollis G; Scherle P; Liu PCC
Clin Cancer Res; 2019 Jan; 25(1):300-311. PubMed ID: 30206163
[TBL] [Abstract][Full Text] [Related]
6. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells.
Wang X; Kilgore MW
Mol Cell Endocrinol; 2002 Aug; 194(1-2):123-33. PubMed ID: 12242035
[TBL] [Abstract][Full Text] [Related]
7. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
8. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3.
Tsuyama N; Danjoh I; Otsuyama K; Obata M; Tahara H; Ohta T; Ishikawa H
Biochem Biophys Res Commun; 2005 Nov; 337(1):201-8. PubMed ID: 16188230
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
Catlett-Falcone R; Landowski TH; Oshiro MM; Turkson J; Levitzki A; Savino R; Ciliberto G; Moscinski L; Fernández-Luna JL; Nuñez G; Dalton WS; Jove R
Immunity; 1999 Jan; 10(1):105-15. PubMed ID: 10023775
[TBL] [Abstract][Full Text] [Related]
10. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.
Ishikawa H; Tsuyama N; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Kawano MM
Leuk Lymphoma; 2003 Sep; 44(9):1477-81. PubMed ID: 14565647
[TBL] [Abstract][Full Text] [Related]
12. A corepressor and chicken ovalbumin upstream promoter transcriptional factor proteins modulate peroxisome proliferator-activated receptor-gamma2/retinoid X receptor alpha-activated transcription from the murine lipoprotein lipase promoter.
Robinson CE; Wu X; Nawaz Z; Onãte SA; Gimble JM
Endocrinology; 1999 Apr; 140(4):1586-93. PubMed ID: 10098492
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling.
Yamamoto T; Matsuda T; Junicho A; Kishi H; Saatcioglu F; Muraguchi A
FEBS Lett; 2000 Dec; 486(2):143-8. PubMed ID: 11113455
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.
Garcia-Bates TM; Bernstein SH; Phipps RP
Clin Cancer Res; 2008 Oct; 14(20):6414-25. PubMed ID: 18927280
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPARγ.
Ji HG; Piao JY; Kim SJ; Kim DH; Lee HN; Na HK; Surh YJ
Mol Nutr Food Res; 2016 Jun; 60(6):1448-57. PubMed ID: 27079734
[TBL] [Abstract][Full Text] [Related]
17. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
[TBL] [Abstract][Full Text] [Related]
18. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
20. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
